Moran Wealth Management’s SLB Ltd SLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.18M Buy
178,577
+40,985
+30% +$1.99M 0.28% 121
2025
Q4
$5.28M Buy
137,592
+35,311
+35% +$1.28M 0.16% 192
2025
Q3
$3.52M Buy
102,281
+1,455
+1% +$50.6K 0.11% 226
2025
Q2
$3.41M Buy
100,826
+22,219
+28% +$771K 0.11% 237
2025
Q1
$3.29M Sell
78,607
-228,523
-74% -$9.36M 0.11% 230
2024
Q4
$11.8M Sell
307,130
-1,766
-0.6% -$74.1K 0.38% 95
2024
Q3
$13M Buy
308,896
+73,432
+31% +$3.27M 0.4% 88
2024
Q2
$11.1M Sell
235,464
-597
-0.3% -$28.8K 0.37% 93
2024
Q1
$12.9M Sell
236,061
-3,717
-2% -$187K 0.42% 85
2023
Q4
$12.5M Sell
239,778
-11,811
-5% -$642K 0.44% 77
2023
Q3
$14.7M Sell
251,589
-8,694
-3% -$504K 0.57% 62
2023
Q2
$12.8M Sell
260,283
-29,350
-10% -$1.4M 0.48% 76
2023
Q1
$14.2M Buy
289,633
+316
+0.1% +$16.8K 0.54% 70
2022
Q4
$15.5M Buy
+289,317
New +$14.4M 0.59% 53

Other funds holding SLB

Moran Wealth Management's SLB Position: Q1 2026 in Review

Moran Wealth Management increased its SLB Ltd (SLB) stake by 30% in Q1 2026, buying an estimated $1.99M and bringing the position to 178,577 shares worth $9.18M. The position accounts for 0.28% of the portfolio, ranked #121.

Moran Wealth Management first reported a position in SLB in Q4 2022 and has held it in 14 quarters since. The position peaked at $15.5M in Q4 2022. 1,680 funds tracked by Wall St. Rank hold SLB as of Q1 2026.

  • Moran Wealth Management held 178,577 shares of SLB Ltd worth $9.18M as of Q1 2026.
  • Moran Wealth Management bought 40,985 SLB Ltd shares in Q1 2026, an estimated $1.99M.
  • SLB Ltd made up 0.28% of Moran Wealth Management's portfolio in Q1 2026, its #121 holding.
  • Moran Wealth Management first reported a position in SLB Ltd in Q4 2022 and has held it in 14 quarters since.
  • Moran Wealth Management's SLB Ltd position peaked at $15.5M in Q4 2022.
  • 1,680 funds tracked by Wall St. Rank held SLB Ltd as of Q1 2026.

Based on Moran Wealth Management's 13F filing for Q1 2026, filed 27 Apr 2026.